Ranbaxy Issues Voluntary Nationwide Recall Of 41 Lots Of Atorvastatin Calcium Tablets 10 Mg, 20 Mg And 40 Mg Due To Potential Presence Of Foreign Substance

Date of Recall
2012-11-28

Recall Details
- November 28, 2012 - Princeton, NJ -- On November 9, 2012, Ranbaxy Inc. initiated a voluntary recall of 41 affected lots of Atorvastatin Calcium Tablets (10 mg, 20 mg and 40 mg) which is a solid oral dosage form, to the retail level. The Company is taking this voluntary action as a precautionary measure due to the fact that we cannot exclude the possibility that the affected lots may contain very small glass particles resembling a fine grain of sand (less than 1 mm in size). This information is available in Ranbaxy's website at www.ranbaxyusa.com. The recall does not affect or relate to the 80 mg dosage strength of Atorvastatin Calcium Tablets.

The probability of an adverse event due to consumption of this product is unlikely but cannot be ruled out. Because of the size of the particles which may be present in the affected lots it is unlikely to cause a significant safety concern. However, the possibility of adverse experiences arising primarily due to physical irritation cannot be ruled out. As of this date, Ranbaxy has not received any reports of adverse events related to this recall.

The product is used to lower blood cholesterol and is packaged in plastic bottles, as 90 and 500 tablets per bottle. The affected lots of Atorvastatin Calcium Tablets and their respective NDC code, expiration date information are listed below. The product is a white colored tablet and can be identified by the imprint RX12 on 10 mg tablets, RX828 on 20 mg tablets and RX829 on 40 mg tablets. The product was distributed in the USA to wholesalers and retailers.

Ranbaxy has notified its distributors and retailers by e-mail/ FedEx and has arranged for return of the affected lots. Distributors/retailers have stopped further distribution of the affected lots and are in the process of returning any affected product to Ranbaxy.

Consumers with questions regarding this recall can contact Ranbaxy's Customer Coordinator (Inmar) at 1-866-266-7623, Monday to Friday, 8:00 AM to 5:00 PM CST. Consumers should immediately contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

Adverse reactions or quality problems experienced with the use of this product may be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

Following is the list of affected lots:

Product Lot number Pack Size NDC # Expiry Date
ATORVASTATIN Calcium Tablets 10mg x 90 2436144 90's Bottle 63304-827-90 31-Aug-14
ATORVASTATIN Calcium Tablets 10mg x 90 2436582 90's Bottle 63304-827-90 31-Aug-14
ATORVASTATIN Calcium Tablets 10mg x 90 2441567 90's Bottle 63304-827-90 31-Aug-14
ATORVASTATIN Calcium Tablets 10mg x 90 2441568 90's Bottle 63304-827-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2436731 90's Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2437381 90's Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2437940 90's Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2437942 90's Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2437945 90's Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2437947 90's Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2437952 90's Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2437953 90's Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2437960 90's Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2440676 90's Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2440677 90's Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2440680 90's Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 20mg x 90 2440681 90's Bottle 63304-828-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 500 2437956 500's Bottle 63304-829-05 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 500 2437957 500's Bottle 63304-829-05 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 500 2440675 500's Bottle 63304-829-05 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2434265 90's Bottle 63304-829-90 31-Jul-14
ATORVASTATIN Calcium Tablets 40mg x 90 2434266 90's Bottle 63304-829-90 31-Jul-14
ATORVASTATIN Calcium Tablets 40mg x 90 2434824 90's Bottle 63304-829-90 31-Jul-14
ATORVASTATIN Calcium Tablets 40mg x 90 2434826 90's Bottle 63304-829-90 31-Jul-14
ATORVASTATIN Calcium Tablets 40mg x 90 2434827 90's Bottle 63304-829-90 31-Jul-14
ATORVASTATIN Calcium Tablets 40mg x 90 2434828 90's Bottle 63304-829-90 31-Jul-14
ATORVASTATIN Calcium Tablets 40mg x 90 2434829 90's Bottle 63304-829-90 31-Jul-14
ATORVASTATIN Calcium Tablets 40mg x 90 2434830 90's Bottle 63304-829-90 31-Jul-14
ATORVASTATIN Calcium Tablets 40mg x 90 2434831 90's Bottle 63304-829-90 31-Jul-14
ATORVASTATIN Calcium Tablets 40mg x 90 2436580 90's Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2436725 90's Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2436727 90's Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2436729 90's Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2437377 90's Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2437380 90's Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2437941 90's Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2437943 90's Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2437944 90's Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2437949 90's Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2437950 90's Bottle 63304-829-90 31-Aug-14
ATORVASTATIN Calcium Tablets 40mg x 90 2437955 90's Bottle 63304-829-90 31-Aug-14

About Ranbaxy Inc.

Ranbaxy Inc. is a wholly owned subsidiary of Ranbaxy Laboratories Limited (RLL), India's largest pharmaceutical company.

Recall Comments

No comments have been posted.
Be the first to add a comment!